Kevin Dawson
About
In The Last Decade
Kevin Dawson
25 papers receiving 812 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 482
- Surgery 175
- Cancer Research 153
- Hepatology 115
- Epidemiology 112
Countries citing papers authored by Kevin Dawson
This map shows the geographic impact of Kevin Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Dawson more than expected).
Fields of papers citing papers by Kevin Dawson
This network shows the impact of papers produced by Kevin Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Dawson. The network helps show where Kevin Dawson may publish in the future.
Co-authorship network of co-authors of Kevin Dawson
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Dawson. A scholar is included among the top collaborators of Kevin Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Dawson. Kevin Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 21 | |
| 3 | 46 | |
| 4 | 17 | |
| 5 | 14 | |
| 6 | 173 | |
| 7 | 34 | |
| 8 | 38 | |
| 9 | 37 | |
| 10 | 13 | |
| 11 | 30 | |
| 12 | 19 | |
| 13 | 24 | |
| 14 | 61 | |
| 15 | 61 | |
| 16 | 61 | |
| 17 | 10 | |
| 18 | Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53. | 15 |
| 19 | 1 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.